30 results about "Human group" patented technology

The invention discloses a human group relation network analysis method and device. The method comprises the steps of collecting video data of multiple sites based on a set data collection format, wherein the collected data comprises human face characteristic value and the structural information of the human face characteristic value; conducting the time delayed relation filtering, geological location mapping, behavioral mode judgment and weight relation network construction on the collected data to obtain the basic information of the human group relation network, conducting relation views filtering to the basic information of the relation network to implement a flexible and configurable relation rendering. The invention further discloses a corresponding device. The video image collection and the human face recognition technologies are introduced to the large scope human group relation network analysis, the broadness and unity of the data sources are achieved, and the broad and accurate human group relation analysis can be achieved.

The present invention relates to a fat-changed milk product and its production method, belonging to the field of milk product processing technology. Said invention is aimed at solving the problem of that in existent natural milk the saturated fatty acid and cholesterol contents are high, so that said natural milk is not suitable for human group with hyperlipemia. Said invention utilizes the change of milkfat to regulate the ratio of saturated and polyunsaturated fatty acids and the ratio of n-3 series and n-6 series fatty acids so as to produce the edible nutrient balance milk product suitable for all the human groups. Said invention also can utilize the milkfat change process to add the olive oil or tea oil with high monounsaturated fatty acid content so as to produce the fat-changed milk product with the actions of reducing blood cholesterol, triglyceride and low-density lipoprotein, or add the perilla herb oil with high alpha-linolenic acid content and fish oil with high DHA content to produce the fat-changed milk product which an meet the infant body development requirements.

The invention discloses a classification method based on velocity vector human group clustering, which comprises the following steps of: 1, dividing each track feature of data returned by a camera according to the number of individuals; wherein the quadruple (r, theta, v, alpha) is included, r is the distance, theta is the orientation, v is the moving speed, and alpha is the moving direction; 2, converting the distance and orientation direct data returned by the radar into Cartesian coordinate description, and taking the position of the radar as an original point; and 3, selecting a Gaussian kernel function for generation through a kernel matrix. The spherical camera positioning assisted by the radar technology has remarkable advantages, and automatic patrol and rapid response of the camera are realized.

The invention relates to a method for high throughput screening compounds by using a plurality of automated cell based assays assessing skeletal muscle cells contractility, morphology, and metabolism, in order to predict the efficacy of said compound on a panel of applications linked with muscle physiological and pathophysiological processes, comprising: (i) providing an in vitro culture of myotubes, wherein the in vitro myotubes culture is obtained by the following method: providing a cell culture device allowing the culture of myoblasts or myotubes, depositing said cells from a human donor or human group of donors, in good health or affected by a muscle related disorder, from primary cells, a cell line, an isogenic cell line or differentiated stem cells recapitulating a muscle disorder, on said culture device by using a method allowing the spatial control of cell culture, culturing said cells during a determined incubation time so as to promote a spatially controlled myotube culture; (ii) adding at least one compound to said culture; (iii) after a determined incubation time of the myotubes with said compound, carrying out structural and / or functional readouts of the myotubes to determine the effect of said compound on the myotubes; and (iv) based on said determined effect, predicting the ability of said compound to improve or alter healthy muscle features, or to treat, rescue, or cure muscle disorders, said features or said disorders being linked with muscle contraction, muscle morphology or muscle metabolism.

A traditional Chinese medicine medicament for lowering the blood pressure and adjusting the blood fat is made from the active component of the tea chromatophore which is extracted and enriched from tea leaves. The characteristics of the invention are that the extracting technique is simple, the concentration rate of the active component is high, and the ointment producing rate is low, thereby the invention is applicable to be made into the advanced medicament types just like the fluid filling hard capsules, the soft capsules and the like. The medicament types detract the extract of the essential medicine sufficiently by the substrates, thereby the invention is beneficial for the absorption, and the oral bioavailability is increased, and further the invention is easy to be accepted by the patients. After the animal experimental certification, the invention has the obvious functions of the blood pressure lowering and the blood fat adjusting. The invention is safe without any toxic side effects. The source of the medicament is extensive, the costs are low, the technique is simple and the invention is easy to spread. The product of the invention can be used as the food or the medicine, the application human groups are extensive, and further the social and the economic benefits are high.

Group C rotaviruses are a cause of acute gastroenteritis in children and adults that is distinct from group A RV. However, human group C rotaviruses cannot be grown in culture, resulting in a lack of tools for detection and treatment of GrpC RV disease. Consequently, the burden of GpC RV disease has not been clearly established. Isolated recombinant human rotavirus group C virus-like particles are provided according to embodiments of the present invention along with methods of their production and use in, inter alia, detection of Grp C RV infection, diagnostic assays and immunogenic compositions.

The invention relates to a recombinant bifidobacterium hRV-VP7 expression vector and the oral vaccine. The invention pertains to the field of genetic engineering. The technical problem to be solved is to construct a new bifidobacterium expression vector of hRV virus VP7 protein. The recombinant bifidobacterium hRV-VP7 expression vector of the invention is loaded with a virus protein VP7 coding gene sequence of a human group A rotavirus. The expression vector of the invention can be transfected into the bifidobacterium and can be further prepared into an hRV / VP7 transgenic bifidobacterium-hRV-VP7 recombinant vector oral live vaccine preparation after fermentation culture. The invention is mainly used for the prevention and adjuvant treatment of infantile diarrhea which is caused by human rotavirus, thus having great market prospect.

The invention relates to a system for determining and adjusting human group and social psychology and behaviors, which comprises the following components: a questioning and answering module, a computation module, an assemble editing module, a classification module and a result module, wherein the computation module is directly associated with the questioning and answering module and the assemble editing module respectively; the assemble editing module is also associated with the classification module; and the result module is associated with a second module, a third module and a fourth module respectively to form an associated whole together. The system enables a user to obtain suggestions or cautions suitable for the psychological behaviors through a humanized design and a humanized using process, so the user obtains a psychological adjusting and obtains a good corresponding technical effect.

The invention discloses a human group A streptococci quantum dot immunochromatography detection card, a preparation method and applications. The detection card comprises a base plate, a sample pad, a combination pad, a detection layer and a water absorption pad. The combination pad is coated with anti-human group A streptococci nano probes labeled with quantum dots. The detection layer is composed of a solid phase nitrocellulose membrane with a detection line and a quality control line. The detection line is coated with mouse-anti-human group A streptococci M protein polyclonal antibodies. The quality control line is coated with anti-rabit IgG. The detection layer is pasted on the base plate. The combination pad and the water absorption pad are pasted with the detection layer and the base plate respectively. The sample pad is arranged on the combination pad, overlaps with part of the combination pad and is pasted with the combination pad and the base plate. The human group A streptococci (M1, 3, 5, 6, 24 serotype) quantum dot immunochromatography detection card with advantages of simple operation, rapid detection, quantification, high sensitivity and the like, a preparation method and applications are provided.

The present invention relates to a functional beverage applicable to IT human group. It is made up by using 30-45g of green tea, 60-80g of mung bean, 15-20g of scallion root, 40-55g of crataegus fruit, 170-180g of honey and 10000 ml of water through a certain preparation process. Besides, said invention also provides the concrete steps of said preparation process.

The invention relates to site-specific integrating expression vectors for therapy Hemophilia B and to methods of preparing them. A vector of the invention contains a human Factor IX gene in a vector constructed using as a chromosome targeting sequence a polynucleotide without any important physiological function-related gene homologous to DNA on the short arms of human group D and human group G chromosomes. The vector of the invention provides high stability of Factor IX expression, high expression efficiency, no immunogenicity and safety in use.

The present invention provides a human source gene targeting sequence a gene vector and gene expression strategies. The invention includes the following: (1) Using a DNA sequence without important physiological function-related genes in the short arms of human group D, G chromosomes, or a DNA sequence sharing 50% or over 50% identity to the sequence selected from human D, G group chromosomes, as a targeting sequence for gene targeting and (2) Construction of a gene vector containing the targeting sequence. the nucleolus organizing region in D, G group chromosomes that is described above is used as the target site, the gene of interest is integrated into the short arms where the gene expresses actively in D,G group chromosomes of human cells. The present invention provides a novel gene targeting sequence by which the gene vector construction and gene expression strategies are realized. The gene expression strategies can be used for human gene therapy and for manufacturing protein.

The invention deals with the gene drugs for therapy Hemophilia B and its method of preparation. It contains human source gene vector-FIX recombinant constructed using DNA sequence as leading sequence of therapy gene without important physiological function-related gene on the short arms of human group D,G chromosomes or to which DNA sequence is homologous. This invention also provides the method of preparing gene drug. The therapy gene of gene drug for hemophilia B has a high stability of expression, safety, high expression efficiency and no immunogenecity.

The present invention relates to a konjak flour suitable for human group with diabetes. Its composition includes (by weight portion) 1000-1400 portions of curcumin, 0.32-0.37 portion of methylpyridine chrome, 27-31 portions of zinc glycinate, 245-255 portions of magnesium sulfate, 850-950 portions of calcium carbonate and 27000-28000 portions of konjak flour. Said invention not only has rich nutrients, but also can be used for regulating blood sugar.

The present invention relates to a portable respirator system with various different special-purpose softwares capable of meeting special requirements for treating different target patient human groups. The described system includes a radio-frequency transmitter, it can be used for transmitting the data into far-end service provider from system, the data which can be transmitted include position information, diagnosis and intervention information. Besides, said system can be combined with defibrillator.

The invention involves a cell line which can express human mutated tissue-type plasminogen activator (TNK-TPA), and its preparation methods. The collection number of cell lines in this invention is CCTCC C200006. We first used a DNA fragment from the short arms of human group D or group G chromosomes or its homolog to construct a recombinant human source gene vector-TNK-TPA (collection number is CCTC m200032); TNK-TPA gene is then incorporated into the target site in the nucleolus organizing region (NOR) of human group D or G chromosomes in host cell line HT1080; of which the recombinant cell line is attained after screening. The recombinant cell line can be used for manufacturing protein.

The invention pertains to the field of genetic engineering, which more particularly relates to a recombinant bifidobacterium hRV-VP4 expression vector and the oral vaccine. The technical problem to be solved is to construct a bifidobacterium expression vector of hRV virus VP4 protein. The recombinant bifidobacterium hRV-VP4 expression vector of the invention is loaded with a virus protein VP4 coding gene sequence of a human group A rotavirus. The expression vector of the invention can be transfected into the bifidobacterium and can be further prepared into an hRV-VP4 transgenic bifidobacterium-hRV-VP4 recombinant vector oral live vaccine preparation after fermentation culture. The invention is mainly used for the prevention and adjuvant treatment of infantile diarrhea which is caused by human rotavirus, thus having great market prospect.

The invention discloses a vinegar-processed egg / soybean / black bean nutrient health-care chewable tablet which comprises the following raw materials in parts by weight: 30-40 parts of vinegar-processed bean flour, 30-40 parts of vinegar-processed egg powder, 10-20 parts of tuckahoe powder, 10-15 parts of pseudo-ginseng powder, 10-15 parts of Plantain seed powder, 5-8 parts of microcrystalline cellulose, 10-20 parts of skimmed milk powder and 10-15 parts of mannitol. The vinegar-processed bean flour is prepared by carrying out vinegar leaching and drying treatment on the soybeans and black beans as the raw materials. The vinegar-processed egg powder is prepared by carrying out vinegar leaching and drying treatment on the eggs used as the raw material. By selecting the mild nonirritating food-borne materials and Chinese herbal medicines, the chewable tablet implements high safety and no side effect, can effectively lower the blood pressure after being eaten for a long time, and can become a novel convenient-eating favorable-pressure-lowering-effect supplementary food for patients with high blood pressure, thereby satisfying the consumption demands of related human groups.

The present invention provides a group of assortment of genes, including 10 genes; L48784, X83300, A1620827, A1494291, NM-020970, BF433657, JO2959, BC 022313, NM-000904 and NM-004994, for screening ductal adenocarcinoma of pancreas. Said invention can utilize detection of said group of genes of human peripheral blood mononuclear cell to screen out patient with pancreatic cancer from health human group.

The invention relates to healthcare tea for invigorating stomach, improving digestion, clearing damp, whitening skin, regulating qi-flowing and strengthening spleen, and a preparation method thereof. The healthcare tea comprises the following raw materials in parts by weight: 4 to 35 parts of tangerine peel, 6 to 45 parts of semen coicis, 2 to 30 parts of fructus crataegi, 3 to 40 parts of fructus fortunellae margaritae, 10 to 56 parts of red jujube fruits, and 1 to 20 parts of fructus lycii. The preparation method comprises: cleaning and crushing all the raw materials into 3 to 30 meshes respectively, mixing the raw materials, and then drying the raw materials at the temperature of 60 to 70 DEG C, so as to obtain the healthcare tea. The raw materials of the healthcare tea provided by the invention contain natural active ingredients, formula matching is scientific, the healthcare tea is safe and free from any toxic and side effects, has the effects of invigorating the stomach, improving the digestion, clearing the damp, whitening the skin, regulating the qi-flowing and strengthening the spleen, and is particularly suitable for being drunk by a human group who suffers from weakness of the spleen and the stomach, has a poor appetite, and suffers from tongue coating, abdominal fullness and distention and lacked energy. Besides, the preparation method is simple, the production cost is low, the operability is strong, and the preparation method facilitates subsequent large-scale application.

The invention relates to an adenoviral vector on the base of human group B adenoviruses, specially of the subtype 11 containing as per invention heterologous elements, inverted terminal repeats (ITRs) in combination with the respective packaging signal of a different serotype virus, preferably of a type B virus. A heterologous promoter, preferably the SV40 promoter is contained and positioned between the packaging signal and the natural position for protein IX in the viral vector. This vector may be additionally deleted in reading frames of the regions E1, E2, E3 or E4. The invention also describes the use of this viral vector for the production of a high capacity vectors based on adenovirus 11, in which the only adenoviral sequences are ITRs and packaging signal and which contains human genomic stuffer sequences. Moreover, cell lines for the amplification of these viral vectors and application of the vectors in medicine are described.

The invention relates to a preparation method of a seasoning, in particular to a soy sauce with rich nutrition and a preparation method thereof. The a soy sauce is prepared from the following raw materials in parts by weight: 30-50 parts of peanut cakes, 30-50 parts of soybean cakes and 10-30 parts of bran. The nutritious soy sauce has a scientific formula and a simple preparation technology, andthe peanut cakes are used in the formula to substitute a majority of hard-won soybean cakes to achieve more balanced and comprehensive nutrition. The invention not only introduces a new seasoning product in the soy sauce market, but also achieves the functions of nutrition and health protection, thereby satisfying the requirements of different human groups for nutrition in a greater limit.